カテゴリ： MarketLine, インドネシア, 企業調査

PT Paninvest Tbk：企業の戦略・SWOT・財務情報

◆英語タイトル：PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11849
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：23
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インドネシア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

PT Paninvest Tbk – Strategy, SWOT and Corporate Finance Report
Summary

PT Paninvest Tbk – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PT Paninvest Tbk (Paninvest), formerly known as PT Panin Insurance Tbk, focuses on tourism and life insurance business. It offers life insurance products such as whole life insurance, unit linked insurance, death insurance, endowment plans, health insurance, personal accident insurance and annuities. It also offers tourism; trading and services; and manual funds. The company, through its products and serves its clientele comprising individuals and corporate customers. The company markets and distributes its products through a network of branches, bancassurance channel, insurance advisors, and marketing offices across the country. The company is a part of Panin Group, a provider of financial services. Paninvest is headquartered in Jakarta, Indonesia.

The company reported gross premiums of IDR3,602.7 billion during fiscal year ended December 2016 (FY2016), a decrease of 4.6% over FY2015. It reported net premium revenues of IDR3,526 billion in FY2016, a decrease of 1.8% over FY2015.

Scope

- Detailed information on PT Paninvest Tbk required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PT Paninvest Tbk in the form of a SWOT analysis
- An in-depth view of the business model of PT Paninvest Tbk including a breakdown and examination of key business segments
- Intelligence on PT Paninvest Tbk’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PT Paninvest Tbk, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PT Paninvest Tbk and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PT Paninvest Tbk as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PT Paninvest Tbk’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
PT Paninvest Tbk: Company Overview 6
PT Paninvest Tbk: Overview and Key Facts 6
PT Paninvest Tbk: Overview 6
PT Paninvest Tbk: Key Facts 6
PT Paninvest Tbk: Key Employees 8
PT Paninvest Tbk: Key Employee Biographies 9
PT Paninvest Tbk: Major Products and Services 10
PT Paninvest Tbk: Company History 11
PT Paninvest Tbk: Management Statement 13
PT Paninvest Tbk: Locations and Subsidiaries 15
PT Paninvest Tbk: Key Competitors 16
PT Paninvest Tbk: Company Analysis 17
PT Paninvest Tbk: Business Description 17
PT Paninvest Tbk: SWOT Analysis 18
PT Paninvest Tbk: SWOT Overview 18
PT Paninvest Tbk: Strengths 18
PT Paninvest Tbk: Weaknesses 19
PT Paninvest Tbk: Opportunities 19
PT Paninvest Tbk: Threats 20
Appendix 21
Contact Us 21
Methodology 21
About MarketLine 22

List of Tables
Table 1: PT Paninvest Tbk: Key Facts
Table 2: PT Paninvest Tbk: Key Employees
Table 3: PT Paninvest Tbk: Company History
Table 4: PT Paninvest Tbk: Locations and Subsidiaries
Table 5: PT Paninvest Tbk: Key Competitors



★海外企業調査レポート[PT Paninvest Tbk：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Crescent Point Energy Corp. (CPG)-石油・ガス分野：企業M&A・提携分析
    Summary Crescent Point Energy Corp. (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and nat …
  • Genera Biosystems Ltd (GBI)：医療機器：M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Beth Israel Deaconess Medical Center Inc-製薬・医療分野：企業M&A・提携分析
    Summary Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics sup …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC)：企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Pharmathen Global BV：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain …
  • Atlantic Power Corporation (ATP)-エネルギー分野：企業M&A・提携分析
    Summary Atlantic Power Corporation (Atlantic Power) is an electric utility that owns and operates diversified power generation assets. It produces electricity from various sources including biomass, coal, hydro, and natural gas sources. The company sells power to utilities and other large commercial …
  • BL&H Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • The Siam Commercial Bank Public Company Limited：企業の戦略・SWOT・財務分析
    The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Molinos Rio de la Plata SA (MOLI3)：企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Vistin Pharma AS (VISTIN)-製薬・医療分野：企業M&A・提携分析
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies solid dosage forms and active pharmaceutical ingredients. The company’s products include metformin, an API for the treatment of diabetes II; opioids, an analgesics and antitussive; …
  • Strongbridge Biopharma plc (SBBP)：企業の財務・戦略的SWOT分析
    Summary Strongbridge Biopharma plc (Strongbridge) formerly Cortendo Plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hyperkalemic …
  • Edgars Stores Limited：企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Novozymes AS (NZYM B)：製薬・医療：M&Aディール及び事業提携情報
    Summary Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning …
  • Europcar Mobility Group SA (EUCAR)：企業の財務・戦略的SWOT分析
    Europcar Mobility Group SA (EUCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • 3M India Limited (3MINDIA)：企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Wns (Holdings) Limited：企業の戦略・SWOT・財務分析
    Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Integra LifeSciences Holdings Corp (IART)：医療機器：M&Aディール及び事業提携情報
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, o …
  • Nidek Co Ltd：企業の戦略的SWOT分析
    Nidek Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ReWalk Robotics Ltd (RWLK)：企業の財務・戦略的SWOT分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • Rexnord Corp (RXN)：企業の財務・戦略的SWOT分析
    Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆